Metagenomi Therapeutics (MGX) vs Genenta Science S.p.A. (SAEN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Genenta Science S.p.A. is the larger company by market cap ($24.5 million vs $21.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MGX | SAEN |
|---|---|---|
| Share price | $0.565 | $0.5074 |
| Market cap | $21.36M | $24.47M |
| 1-day change | -7.95% | -9.39% |
| YTD return | -65.12% | — |
| 1-year return | -62.58% | — |
| EPS (TTM) | $-2.50 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $25.21M | — |
| Revenue growth (YoY) | -51.79% | — |
| Net income (latest FY) | $-87.87M | — |
| Operating margin | -380.85% | — |
| Net margin | -348.54% | — |
| 52-week high | $1.87 | $2.58 |
| 52-week low | $0.562 | $0.50 |
| Distance from 52-week high | -69.79% | -80.33% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1138.94% | — |
| Average volume | 163.21K | 85.01K |
| Shares outstanding | 37.81M | 48.22M |
| Employees | 113 | 9 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Metagenomi Therapeutics
MGX stock →Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 113 employees
About Genenta Science S.p.A.
SAEN stock →Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 9 employees
MGX vs SAEN FAQ
Which is bigger, Metagenomi Therapeutics or Genenta Science S.p.A.?
Genenta Science S.p.A. (SAEN) is larger, with a market capitalization of $24.47M compared with $21.36M for Metagenomi Therapeutics (MGX).
Are Metagenomi Therapeutics and Genenta Science S.p.A. in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.